| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 199,259 | 178,260 | 127,499 | | Cost of Revenue | 67,837 | 57,115 | 43,368 | | | Gross Profit | 131,422 | 121,145 | 84,131 | | | Operating Expenses | | Research Development | 40,293 | 37,393 | 25,654 | | Selling General and Administrative | 113,439 | 103,748 | 74,715 | | Non Recurring | 1,447 | 197 | 632 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (23,757) | (20,193) | (16,870) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,132 | 4,036 | (7,049) | | Earnings Before Interest And Taxes | (22,625) | (16,157) | (23,919) | | Interest Expense |
-
|
-
| 88 | | Income Before Tax | (22,625) | (16,157) | (24,007) | | Income Tax Expense | 788 | 967 | 375 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,413) | (17,124) | (24,382) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (23,413) | (17,124) | (24,382) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,413) | ($17,124) | ($24,382) |
|
0.29% Nasdaq 
0.01 (0.12%) 
Income Statement
